Try our Advanced Search for more refined results
July 24, 2013
Cornerstone Biopharma Inc. et al v. Exela Pharma Sciences LLC et al
Case Number:
1:13-cv-01275
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 24, 2013
Cornerstone Sues Exela Over Generic Hypertension Drug
Cornerstone Therapeutics Inc. on Wednesday told a Delaware federal judge that Exela Pharma Sciences LLC infringed two of its patents when it asked the FDA to approve a generic version of its hypertension drug before the original patent expired.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login